BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2660711)

  • 1. [Rheumatologic effects of etretinate].
    Cuny JF; Schmutz JL; Terver MN; Aussedat R; Cointin M; Weber M; Beurey J
    Ann Dermatol Venereol; 1989; 116(2):95-102. PubMed ID: 2660711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone complications from chronic etretinate intoxication in children].
    Cointin M; Sommelet-Olive D; Cuny JF; Bretagne MC
    Ann Pediatr (Paris); 1990 Sep; 37(7):458-60. PubMed ID: 2256641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate.
    DiGiovanna JJ; Helfgott RK; Gerber LH; Peck GL
    N Engl J Med; 1986 Nov; 315(19):1177-82. PubMed ID: 3463863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective radiographic study of skeletal changes after long-term etretinate therapy.
    Melnik B; Glück S; Jungblut RM; Goerz G
    Br J Dermatol; 1987 Feb; 116(2):207-12. PubMed ID: 3828215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Unwanted bone changes in systemic treatment with synthetic retinoids].
    Melnik B; Plewig G
    Hautarzt; 1987 Apr; 38(4):193-7. PubMed ID: 3474220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hip and spinal ossification enthesopathies induced by etretinate therapy in peripheral psoriatic arthritis].
    Bologna C; Poirier JL; Hérisson C; Simon L
    Rev Rhum Mal Osteoartic; 1991 Oct; 58(9):595-9. PubMed ID: 1775906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis is a toxic effect of long-term etretinate therapy.
    DiGiovanna JJ; Sollitto RB; Abangan DL; Steinberg SM; Reynolds JC
    Arch Dermatol; 1995 Nov; 131(11):1263-7. PubMed ID: 7503569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal hyperostosis and extraosseous calcification in patients receiving long-term etretinate (Tigason).
    Wilson DJ; Kay V; Charig M; Hughes DG; Creasy TS
    Br J Dermatol; 1988 Nov; 119(5):597-607. PubMed ID: 3207613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retinoid-induced changes of the bones and ligaments].
    Zelger B; Frank R; Kemmler G; Fritsch P
    Hautarzt; 1990 Oct; 41(10):537-44. PubMed ID: 2258296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone changes in children on long-term treatment with etretinate.
    Halkier-Sørensen L; Laurberg G; Andresen J
    J Am Acad Dermatol; 1987 May; 16(5 Pt 1):999-1006. PubMed ID: 3584585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone changes in long-term therapy with etretinate (Tigason)].
    Haustein UF; Heilmann S
    Z Hautkr; 1987 Mar; 62(5):395-6, 399-400. PubMed ID: 3590912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An appraisal of acitretin therapy in children with inherited disorders of keratinization.
    Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI
    Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skeletal changes following long-term treatment with retinoids].
    Montag M; Reiser M; Hamm H; Traupe H; Vogt HJ
    Radiologe; 1988 Jul; 28(7):320-5. PubMed ID: 3045876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retinoids: the new status. Maintenance therapy, disorders of resorption in "non-responders", interactions and interferences with drugs, treatment of children and bone toxicity, acitetin and 13-cis-acitretin].
    Orfanos CE
    Hautarzt; 1989 Mar; 40(3):123-9. PubMed ID: 2523875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive spinal hyperostosis in a patient receiving isotretinoin--progression after 4 years of etretinate therapy.
    Archer CB; Elias PM; Lowe NJ; Griffiths WA
    Clin Exp Dermatol; 1989 Jul; 14(4):319-21. PubMed ID: 2591100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for skeletal toxicity of children treated with etretinate.
    Glover MT; Peters AM; Atherton DJ
    Br J Dermatol; 1987 May; 116(5):609-14. PubMed ID: 3297126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature epiphyseal closure--a complication of etretinate therapy in children.
    Prendiville J; Bingham EA; Burrows D
    J Am Acad Dermatol; 1986 Dec; 15(6):1259-62. PubMed ID: 3805366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcifying arthropathy of the hips and diffuse hyperostosis associated with etretinate.
    Cerio R; Wells RS; MacDonald DM
    Clin Exp Dermatol; 1987 Mar; 12(2):129-31. PubMed ID: 3677472
    [No Abstract]   [Full Text] [Related]  

  • 19. Cortical hyperostosis and enthesopathy due to long-term etretinate administration.
    Guit GL; Obermann WR; van der Schroeff JG; Sillevis-Smitt HJ
    Diagn Imaging Clin Med; 1986; 55(4-5):214-8. PubMed ID: 3095013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of bone changes in adults treated with etretinate.
    Halkier-Sørensen L; Andresen J
    J Am Acad Dermatol; 1989 Jan; 20(1):83-7. PubMed ID: 2913084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.